Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
Pfizer (NYSE: PFE) stock has been in the dumps this year. It is struggling due to declining demand for its COVID products. And it may take some years before its top line starts rising meaningfully again. The company's recent forecast didn't help matters, either. But with the stock losing close to…#pfe #pfizer #seagen #davidjagielski #motleyfool (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2023 Category: Consumer Health News Source Type: news
Are Investors Overreacting to Pfizer's Underwhelming Forecast for 2024?
Pfizer (NYSE: PFE) stock has been in the dumps this year. It is struggling due to declining demand for its COVID products. And it may take some years before its top line starts rising meaningfully again. The company's recent forecast didn't help matters, either. But with the stock losing close to…#pfe #pfizer #seagen #davidjagielski #motleyfool (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2023 Category: Consumer Health News Source Type: news
End-of-Year Tax Checklist: Take Steps Now to Maximize Your Tax Refund in 2024
The winter holiday season might not bring to mind your income taxes, which aren't due to be filed until April 15, 2024, but the end of the year can be an excellent time for checking your financial situation and making changes to your situation to improve your tax refund or liability for 2023.…#w4 #pfizer #energystar #rmd #agi (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2023 Category: Consumer Health News Source Type: news
Hospira, Inc. Issues A Voluntary Nationwide Recall For One Lot of Bleomycin for Injection, USP 15 Units Single Dose ONCO-TAIN ™ Glass Fliptop Vial Due To The Potential For Presence of Glass Particulate Matter
Hospira, Inc., a Pfizer company, is voluntarily recalling one lot of Bleomycin for Injection, USP 15 units Single Dose ONCO-TAIN ™ Glass Fliptop Vial, lot BL12206A, to the user level. The recall was initiated due to a confirmed customer report for the presence of glass particulate within a single via (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 22, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Here are the big health sector themes to watch next year
The health-care sector has wiped out much of its losses for the year during the December market rally. Beaten-down biotech and medical device makers have seen the biggest rebound this month, and analysts see that momentum continuing in the new year. Still, analysts and strategists have a mixed…#samstovall #cfra #jpmorgan #pfizer #elililly #medicare #meenaseshamani #centerformedicare #victorbulto #novartis (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2023 Category: Consumer Health News Source Type: news
Texas ’ Ken Paxton sued after seeking out-of-state medical records
Texas Attorney General Ken Paxton is a very busy man. On the one hand, the Republican lawyer is having to keep up with a variety of serious and ongoing controversies: The Lone Star State’s chief law enforcement official is under indictment and members of his own team have made multiple criminal…#kenpaxton #lonestarstates #paxton #pfizer #mediamatters #elonmusks #katecoxs #seattle #texastribune (Source: Reuters: Health)
Source: Reuters: Health - December 22, 2023 Category: Consumer Health News Source Type: news
Better Bull Market Buy: CRISPR Therapeutics vs. Pfizer Stock
"The thrill of victory and the agony of defeat." That phrase became well-known years ago thanks to sportscaster Jim McKay. And it pretty much sums up the different trajectories for CRISPR Therapeutics (NASDAQ: CRSP) and Pfizer (NYSE: PFE) in 2023. CRISPR Therapeutics has enjoyed the thrill of…#jimmckay #crisprtherapeutics #pfe #pfizer #motleyfool #adriacimino #keithspeights #comirnaty #rsv #nurtec (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2023 Category: Consumer Health News Source Type: news
Pfizer's chaotic year wraps up with plunging stock, grim guidance
Investors who own Pfizer Inc. NYSE: PFE may have expected 2023 to be what football teams call a "rebuilding year." The company shifted its focus away from COVID-19 drugs and toward potential deals, share buybacks, and new treatments in its pipeline. While rebuilding years are often messy, Pfizer's…#pfizerinc #pfe #pfizer #xlv #modernainc #seagen #ubs #barclays #truist #marketbeat (Source: Reuters: Health)
Source: Reuters: Health - December 21, 2023 Category: Consumer Health News Source Type: news
Is Pfizer Stock A Sell After Its 2024 Outlook Disappoints And Weighs On Shares?
Is Pfizer stock a sell after its 2024 outlook missed analysts' expectations and weighed on shares? Is PFE stock a sell? The post Is Pfizer Stock A Sell After Its 2024 Outlook Disappoints And Weighs On Shares? appeared first on Investor's Business Daily.#pfizer #pfe #outlookdisappoints (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
Want $1,500 in Dividend Income in 2024? Invest $25,000 in These 3 Top Income Stocks
Dividend income can boost your overall returns, and also provide you with some recurring cash flow for your portfolio. That's a good thing, because it means you don't have to sell your investments if you need cash -- you can just wait for the dividend income to roll in. And while the S&P 500 is…#kraftheinz #att #pfe #kraft #heinz #philadelphia #oscarmayer #warrenbuffett #berkshirehathaway #pfizer (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
3 Stocks Near Multiyear Lows That Could Bounce Back in 2024
When a company underperforms, the markets sometimes have a tendency to overreact. An earnings miss or a guidance cut can at times be enough to lead to a significant sell-off, even if the underlying business remains a sound investment. Heading into 2024, there are three struggling stocks that are…#dollartree #dollargeneral #pfe #familydollar #toddvasos #pfizer #comirnaty #seagen #davidjagielski #motleyfool (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
3 Stocks to Snatch Up on Tax-Loss Harvesting Dips
Strategically infusing tax-loss harvesting and stocks with fundamental and long-term value growth Tax-loss harvesting is a strategic financial tactic investors employ to leverage market downturns for potential gains. The process involves selling securities at a loss to offset or minimize capital…#alibaba #gmv #pfizer #nurtec #cgrp #scd #transthyretinamyloid #paramount #showtime #arpu (Source: Reuters: Health)
Source: Reuters: Health - December 20, 2023 Category: Consumer Health News Source Type: news
5 of the Safest High-Yield Dividend Stocks to Buy for 2024
In less than two weeks, Wall Street and investors will be welcoming in a new year. Although 2023 has been a banner year for equities, highlighted by the outperformance of the high-growth "Magnificent Seven," it's dividend stocks that should be on investors' radar as we prepare to open the curtain…#magnificentseven #verizon #realtyincome #cre #spiritrealtycapital #pfizer #pfe #greatrecession #seagen #pfizerspecialcare (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2023 Category: Consumer Health News Source Type: news
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
The combination therapy was hailed with a standing ovation in October at the European Society for Medical Oncology (ESMO) conference in Madrid. Less than two months later, the FDA has added its acclaim—blessing it five months ahead of its PDUFA date. On Friday the U.S. regulator signed off on…#fda #pfizerspadcev #merck #keytruda #seagen #ahsanarozullah #rogerdansey #pfizer #padcev #pd1 (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2023 Category: Consumer Health News Source Type: news
3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?
When stocks are being deeply discounted smart investors know it may be time to go shopping. Dumpster diving can be fun when looking for beaten-down stocks to buy. Many times deeply discounted companies are simply mispriced by the market. Too much importance is placed on a one-time event or a…#dumpster #pfizer #seagen #confectionerhershey #hershey #mordorintelligence #michellebuck #meme #amcentertainment #amc (Source: Reuters: Health)
Source: Reuters: Health - December 19, 2023 Category: Consumer Health News Source Type: news
